# Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-endpoints-for-the-approval-of-non-small-cell-lung-cancer-drugs-and-biologics/8e9a6bba-beb8-4d9a-8054-5bfd214b7427

> FDA guidance document: Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics. Issue date: April 22, 2015. Get complete insights and analysis.

---

## Details

- Title: Clinical Trial Endpoints for the Approval of Non-Small Cell Lung Cancer Drugs and Biologics
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2015-04-22
- Last Changed: 2020-05-07
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2011-D-0432">FDA-2011-D-0432</a>

## Related Documents

- [Integrated Summary of Effectiveness](https://www.globalkeysolutions.net/guidances/guidance-document/integrated-summary-of-effectiveness/dceeebd6-6607-4d3c-beb9-417012c9a968)
- [Clinical Trial Endpoints for the Approval of Cancer Drugs and Biologics:  Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-endpoints-for-the-approval-of-cancer-drugs-and-biologics-guidance-for-industry/2ab76b05-d847-445c-b212-0047a592f760)
- [Clinical Trial Imaging Endpoint Process Standards Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/clinical-trial-imaging-endpoint-process-standards-guidance-for-industry/910804b6-9e1d-47f8-8105-89b586c9622b)